NHMRC to Fund Major Phase 2 Clinical Trial of Cynata’s Cymerus MSCs in Patients with Osteoarthritis
pharmaceutical investing Cynata CYP-001 Stem Cell Therapy Meets All Safety and Efficacy Endpoints in Phase 1 Trial in GvHD
Silver Hammer Prepares for Drill Program at Its 100% Owned California Patented Claim at The Eliza Project in Nevada